AR105439A1 - Procedimientos de purificación de un virus producido in vitro y ensayo de eliminación del virus - Google Patents
Procedimientos de purificación de un virus producido in vitro y ensayo de eliminación del virusInfo
- Publication number
- AR105439A1 AR105439A1 ARP160102226A ARP160102226A AR105439A1 AR 105439 A1 AR105439 A1 AR 105439A1 AR P160102226 A ARP160102226 A AR P160102226A AR P160102226 A ARP160102226 A AR P160102226A AR 105439 A1 AR105439 A1 AR 105439A1
- Authority
- AR
- Argentina
- Prior art keywords
- virus
- pseudo
- enveloped
- sample
- fraction
- Prior art date
Links
- 241000700605 Viruses Species 0.000 title abstract 10
- 238000000034 method Methods 0.000 title abstract 7
- 238000000746 purification Methods 0.000 title abstract 4
- 230000008030 elimination Effects 0.000 title 1
- 238000003379 elimination reaction Methods 0.000 title 1
- 239000003599 detergent Substances 0.000 abstract 3
- 238000000338 in vitro Methods 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 238000003556 assay Methods 0.000 abstract 1
- 239000001963 growth medium Substances 0.000 abstract 1
- 244000309711 non-enveloped viruses Species 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D7/00—Compositions of detergents based essentially on non-surface-active compounds
- C11D7/22—Organic compounds
- C11D7/26—Organic compounds containing oxygen
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D7/00—Compositions of detergents based essentially on non-surface-active compounds
- C11D7/22—Organic compounds
- C11D7/34—Organic compounds containing sulfur
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C12N7/02—Recovery or purification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/706—Specific hybridization probes for hepatitis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/706—Specific hybridization probes for hepatitis
- C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
- G01N33/5768—Hepatitis A
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D2111/00—Cleaning compositions characterised by the objects to be cleaned; Cleaning compositions characterised by non-standard cleaning or washing processes
- C11D2111/10—Objects to be cleaned
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14051—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14311—Parvovirus, e.g. minute virus of mice
- C12N2750/14351—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/28011—Hepeviridae
- C12N2770/28111—Hepevirus, e.g. hepatitis E virus
- C12N2770/28151—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
- C12N2770/32451—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32511—Parechovirus, e.g. human parechovirus
- C12N2770/32551—Methods of production or purification of viral material
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Emergency Medicine (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Procedimientos de purificación de un virus producido in vitro y ensayo de eliminación del virus. En el presente documento se da a conocer un procedimiento para la purificación de un virus no envuelto o pseudoenvuelto producido in vitro que utiliza una composición con al menos un detergente. También se da a conocer un procedimiento para la purificación que puede utilizar múltiples detergentes y un procedimiento para la determinación de la presencia y/o el nivel de un virus no envuelto o pseudoenvuelto en una muestra. Reivindicación 12: Procedimiento para medir el nivel de un virus no envuelto o pseudoenvuelto en una muestra, comprendiendo el procedimiento las etapas de: a) proporcionar la muestra a una mezcla que comprende una línea celular y un medio de cultivo; b) incubar para permitir la propagación del virus no envuelto o el virus pseudoenvuelto, si está presente en la muestra, para obtener una fracción incubada; c) tratar con al menos un detergente para obtener una fracción tratada; d) recoger una parta de la fracción tratada para obtener una fracción recogida; y e) medir el nivel del virus no envuelto o pseudoenvuelto en la fracción recogida.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562196004P | 2015-07-23 | 2015-07-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR105439A1 true AR105439A1 (es) | 2017-10-04 |
Family
ID=56418394
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP160102226A AR105439A1 (es) | 2015-07-23 | 2016-07-22 | Procedimientos de purificación de un virus producido in vitro y ensayo de eliminación del virus |
Country Status (21)
Country | Link |
---|---|
US (1) | US10336988B2 (es) |
EP (1) | EP3121268B1 (es) |
JP (1) | JP6734137B2 (es) |
KR (1) | KR102205026B1 (es) |
CN (1) | CN106367402B (es) |
AR (1) | AR105439A1 (es) |
AU (1) | AU2016206243B2 (es) |
BR (1) | BR102016016678A2 (es) |
CA (1) | CA2937089C (es) |
ES (1) | ES2712664T3 (es) |
IL (1) | IL246769B (es) |
MX (1) | MX2016009266A (es) |
MY (1) | MY179359A (es) |
PL (1) | PL3121268T3 (es) |
PT (1) | PT3121268T (es) |
RU (1) | RU2691026C1 (es) |
SG (1) | SG10201605869QA (es) |
TR (1) | TR201902201T4 (es) |
TW (1) | TW201704467A (es) |
UY (1) | UY36795A (es) |
ZA (1) | ZA201604895B (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20210031000A (ko) | 2018-01-29 | 2021-03-18 | 그리폴스 다이어그노스틱 솔루션즈 인크. | 임상 시료 내의 파보바이러스 b19를 균질화하기 위한 방법 |
KR20210079543A (ko) | 2019-12-20 | 2021-06-30 | 삼성전자주식회사 | 고대역폭 메모리 및 이를 포함하는 시스템 |
JP2023141423A (ja) * | 2022-03-24 | 2023-10-05 | 国立大学法人 東京大学 | ウイルスの精製方法 |
CN115181816B (zh) * | 2022-08-10 | 2023-01-06 | 杭州纽创生物检测有限公司 | 一种超低病毒滴度体系中病毒滴度的检测方法及其应用 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4721675A (en) * | 1982-02-01 | 1988-01-26 | Abbott Laboratories | Production of hepatitis A virus in vitro utilizing a persistently virus infected cell culture system |
DZ1706A1 (fr) * | 1992-08-07 | 2002-02-17 | Merck & Co Inc | Vaccin contre le virus de l'hepatite a. |
FR2696748B1 (fr) * | 1992-10-14 | 1994-12-30 | Pasteur Merieux Serums Vacc | Procédé de préparation d'antigènes et de vaccins de l'hépatite A (HAV). |
CN101397335A (zh) * | 1998-06-24 | 2009-04-01 | 基因创新有限公司 | Hcv包膜蛋白颗粒:用于疫苗接种的用途 |
WO2003030624A2 (en) * | 2001-10-12 | 2003-04-17 | Chiron Corporation | Hepatitis a virus nucleotide sequences, recombinant proteins and uses thereof |
CN101018804A (zh) * | 2004-07-27 | 2007-08-15 | 基诺美生物工程(制药)公司 | 纯化病毒包膜的方法 |
US7944468B2 (en) * | 2005-07-05 | 2011-05-17 | Northrop Grumman Systems Corporation | Automated asymmetric threat detection using backward tracking and behavioral analysis |
JP5034040B2 (ja) * | 2006-07-13 | 2012-09-26 | 国立大学法人鳥取大学 | 肝炎の診断キット及び診断マーカー |
ES2887335T3 (es) * | 2010-03-17 | 2021-12-22 | Univ Cornell | Vacuna contra las drogas de abuso basada en adenovirus alterado |
-
2016
- 2016-07-13 PL PL16179299T patent/PL3121268T3/pl unknown
- 2016-07-13 PT PT16179299T patent/PT3121268T/pt unknown
- 2016-07-13 IL IL246769A patent/IL246769B/en active IP Right Grant
- 2016-07-13 ES ES16179299T patent/ES2712664T3/es active Active
- 2016-07-13 EP EP16179299.9A patent/EP3121268B1/en active Active
- 2016-07-13 TR TR2019/02201T patent/TR201902201T4/tr unknown
- 2016-07-15 RU RU2016128956A patent/RU2691026C1/ru active
- 2016-07-15 ZA ZA2016/04895A patent/ZA201604895B/en unknown
- 2016-07-15 MX MX2016009266A patent/MX2016009266A/es active IP Right Grant
- 2016-07-15 UY UY0001036795A patent/UY36795A/es unknown
- 2016-07-18 MY MYPI2016702601A patent/MY179359A/en unknown
- 2016-07-18 SG SG10201605869QA patent/SG10201605869QA/en unknown
- 2016-07-19 US US15/213,740 patent/US10336988B2/en active Active
- 2016-07-19 AU AU2016206243A patent/AU2016206243B2/en active Active
- 2016-07-19 BR BR102016016678-0A patent/BR102016016678A2/pt active Search and Examination
- 2016-07-20 TW TW105122891A patent/TW201704467A/zh unknown
- 2016-07-20 CN CN201610576006.2A patent/CN106367402B/zh active Active
- 2016-07-22 CA CA2937089A patent/CA2937089C/en active Active
- 2016-07-22 KR KR1020160093643A patent/KR102205026B1/ko active IP Right Grant
- 2016-07-22 JP JP2016144066A patent/JP6734137B2/ja active Active
- 2016-07-22 AR ARP160102226A patent/AR105439A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
AU2016206243B2 (en) | 2021-04-01 |
CN106367402B (zh) | 2022-03-08 |
RU2691026C1 (ru) | 2019-06-07 |
UY36795A (es) | 2016-09-30 |
CA2937089A1 (en) | 2017-01-23 |
IL246769A0 (en) | 2016-12-29 |
ES2712664T3 (es) | 2019-05-14 |
TW201704467A (zh) | 2017-02-01 |
TR201902201T4 (tr) | 2019-03-21 |
US20170022480A1 (en) | 2017-01-26 |
KR20170012141A (ko) | 2017-02-02 |
KR102205026B1 (ko) | 2021-01-19 |
EP3121268B1 (en) | 2018-12-26 |
CN106367402A (zh) | 2017-02-01 |
US10336988B2 (en) | 2019-07-02 |
ZA201604895B (en) | 2021-04-28 |
BR102016016678A2 (pt) | 2019-02-12 |
MY179359A (en) | 2020-11-05 |
PL3121268T3 (pl) | 2019-06-28 |
JP2017023144A (ja) | 2017-02-02 |
SG10201605869QA (en) | 2017-02-27 |
CA2937089C (en) | 2024-02-06 |
PT3121268T (pt) | 2019-02-26 |
JP6734137B2 (ja) | 2020-08-05 |
AU2016206243A1 (en) | 2017-02-09 |
EP3121268A1 (en) | 2017-01-25 |
IL246769B (en) | 2020-09-30 |
MX2016009266A (es) | 2017-01-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR105439A1 (es) | Procedimientos de purificación de un virus producido in vitro y ensayo de eliminación del virus | |
CO2018009434A2 (es) | Anticuerpos monoclonales de proteína ns1 anti-virus del dengue | |
EA201592074A1 (ru) | Композиции и способы изменения сигнальной системы вторичного мессенджера | |
BR112015022934A2 (pt) | esteroides neuroativos, composições, e uso do mesmo | |
MX2022014633A (es) | Metodos para detectar norovirus. | |
BR112014020083A8 (pt) | Dispositivos indicadores biológicos de esterilização e métodos de uso | |
EA201992748A1 (ru) | Диагностические анализы для обнаружения, количественного определения и/или отслеживания микроорганизмов и других аналитов | |
BR112017025051A2 (pt) | ensaio celular para detecção de homodímeros anti-cd3 | |
MY192493A (en) | Urinalysis device and dry reagent for quantitative urinalysis | |
WO2015157704A3 (en) | Methods and compositions for detecting misfolded proteins | |
CR20130657A (es) | Ensayo de lisiloxidasa-homólogo 2 y métodos de uso del mismo | |
CY1120220T1 (el) | Μεθοδοι και κυτια για προσδιορισμο της καταστασης λοιμωξης απο φυματιωση | |
BR112017006315A2 (pt) | agente terapêutico, uso de um agente terapêutico, métodos in vitro para determinar se um sujeito com melanoma tem um risco maior de desenvolver metástase, de determinação de um regime de tratamento para um sujeito que sofre de melanoma, de tratamento de um sujeito que sofre de melanoma, ensaio in vitro para predizer o risco aumentado de metástase e kits | |
EP4067507A3 (en) | Pna probes, kits and methods for detecting genotypes of human papillomavirus | |
ES2638294T3 (es) | Método de detección de cáncer | |
BR112014026440A2 (pt) | assays, methods and apparatus for assessing rna disruption | |
BR112017011026A2 (pt) | métodos analíticos e arranjos para uso nos mesmos | |
BR112019005167A2 (pt) | método e kit para analisar uma amostra | |
BR112018011224A2 (pt) | processo de avaliação do risco de complicações nos pacientes que apresentam uma síndrome da resposta inflamatória sistêmica (sirs) | |
ES2530743T3 (es) | Método in vitro y kit para el pronóstico o predicción de la respuesta por parte de pacientes con artritis reumatoide al tratamiento con agentes bloqueantes del factor TNFalfa | |
BR112017021318A2 (pt) | método implementado por computador, e mídia legível por computador | |
CL2023000476A1 (es) | Anticuerpos monoclonales, composiciones y métodos para detectar el factor d de complemento | |
CO2018001917A2 (es) | Método de detección de virus causante de enfermedades respiratorias por virus respiratorio sincitial y metapneumovirus humano | |
PE20181498A1 (es) | Anticuerpos monoclonales especificos para el antigeno piii de adenovirus humano (adv), producidos y secretados por hibridomas celulares, utiles para la deteccion y el diagnostico de la infeccion causada por adv | |
BR112016002709A2 (pt) | queratinas como biomarcadores para câncer cervical e sobrevivência |